Download PDF
CC BY-NC-ND 4.0 · Ann Natl Acad Med Sci 2016; 52(02): 100-108
DOI: 10.1055/s-0040-1712610
Original Article

Japanese encephalitis virus: Uniqueness of immune response, vaccine development and future challenges

Milind M. Gore
National Institute of Virology, Gorakhpur Unit BRD Medical College campus, Gorakhpur.
› Author Affiliations
› Further Information
Also available at
  PDF Download Permissions and Reprints

ABSTRACT

Japanese encephalitis virus (JEV) is a major seasonal health problem in many rural areas in India and other parts of Asia. Transmission of virus is through mosquito vectors biting followed by peripheral multiplication site and exposed to host immune response before it succeeds in invasion of CNS. Thus protection from viral infection is a complex interplay of fight for superiority by virus and the host.

Cell mediated immune response using transferred to non-immune 14 day mice and lethally challenged to study the protection. Results indicated that dominant immune response of T helper (Th) 2 type. Th and neutralizing antibody inducing epitopes on JEV were identified by combination of immunological and Bioinformatics platforms. Chimeric peptides incorporating both Th and B cell epitopes could protect mice. These epitopes were further incorporated in polytope DNA construct with four chimeric peptides and induce protective immunity in mice. In addition, overcome the anergy development by traditional DNA vaccine plasmid than of CMV promoter using antigen specific cell promoter rather was also studied.

NIV carried out extensive studies on JE inactivated vaccines over the years. Studies were carried out mainly using CEC and Vero cells. Isolated of JEV from Kolar (821564) was extensively studied and thermostable mutant (821564 –XY) was selected and characterized genetically as well as antigenically. A commercial successfully produced purified, inactivated vaccine JENVAC is licensed is being successfully. Future challenges in terms of single dose vaccine with long lasting immunity, pig immunization vaccine as well newer related flavivirus are also important.

DR. PRAN NATH CHHUTTANI ORATION delivered during NAMSCON 2015 at the All-India Institute of Medical Sciences, Patna.




Publication History

Article published online:
09 May 2020

© .

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India

 

  • REFERENCES

  • 1 Myint KS, Kipar A, Jarman RG, et al. (2014). Neuropathogenesis of Japanese Encephalitis in a Primate Model. PLoS Negl Trop Dis 8: e2980. doi:10.1371
  • 2 Gore MM (2014) . A cute Encephalitis Syndrome in India: Complexity of the Problem. J Commun Dis 46: 35- 49.
  • 3 CDC JEV fact sheet — /http://www.cdc.gov/ncidod/dvbid/ jencephalitis/facts.htm.
  • 4 King NJ, Getts RD, Getts TM, Rana S, Shrestha B, Kesson MA (2007). Immunopathology of flavivirus infections. Immunol Cell Biol 85: 33-42.
  • 5 Munz C, Steinman RM, Fujii S (2005). Dendritic cell maturation by innate lymphocytes: coordinated stimulation of innate and adaptive immunity. J Exp Med 202: 203–207.
  • 6 Sooryanarain H, Sapkal GN, Gore MM (2012). Pathogenic and v accin e s t r ai n s o f J ap an es e encephalitis virus elicit different levels of human macrophage effector functions. Arch Virol Arch 157:1905-1918.
  • 7 Sooryanarain H, Ayachit V, Gore M ( 2 0 1 2 ) . A c t i v a t e d C D 5 6 ( + ) lymphocytes (NK+NKT) mediate immunomodulatory and anti-viral effects during Japanese encephalitis virus infection of dendritic cells invitro. Virology 432 : 250-260.
  • 8 Biswas SM, Kar S, Singh R, et al. ( 2 0 1 0 ) . I m m u n o m o d u l a t o r y cytokines determine the outcome of J a p a n e s e e n c e p h a l i t i s v i r u s infection in mice. J Med Virol 82:304-310.
  • 9 Biswas SM, Ayachit VM, Sapkal GN, Mahamuni SA, Gore MM (2009). Japanese encephalitis virus produces a CD4+ Th2 response and associated immunoprotection in an adoptive-transfer murine model. J Gen Virol 90 : 818-826.
  • 10 Singh A, Mitra M, Sampath G, et al. (2015). A Japanese encephalitis vaccine from India induces durable and cross-protective immunity against temporally and spatially wide-ranging global field strains. J Infect Dis 212 : 715-725.
  • 11 Kutubuddin M, Kolaskar AS, Galande S, Gore MM, Ghosh SN, Banerjee K (1991). Recognition of h e l p e r T c e l l e p i t o p e s i n envelope(E) glycoprotein of Japanese encephalitis, West Nile and Dengue viruses. Mol Immunol 28: 149-154.
  • 12 Dewasthaly SS, Bhonde GS, Shankarraman V, Biswas SM, Ayachit VM, Gore MM (2007). Chimeric T helper- B cell peptides induce protective response against Japanese encephalitis virus in mice. Protein and Peptide Letters 14: 543-551.
  • 13 Kutubuddin M, Gore MM, Banerjee K, Ghosh SN, Kolaskar AS (1993). Analysis of computer predicted antibody inducing epitope on Japanese encephalitis virus. Acta Virol 37: 417-428.
  • 14 Kulkarni R, Sapkal G, Mahishi L, Shil P, Gore MM (2012). Design and characterization of polytope construct with multiple B and T(H) epitopes of Japanese encephalitis virus. Virus Res 166:77-86.
  • 15 Kulkarni R, Sapkal G, Gore M (2012). Evaluation of Japanese encephalitis virus polytope DNA vaccine candidate in BALB/c mice. Virus Research 170: 118– 125.
  • 16 Ahsan MF, Gore MM (2011). Comparative analysis of macrophage associated vectors for use in genetic vaccine. Virus Res 9:10-22.
  • 17 Ahsan MF, Gore MM (2011). Comparison of immune response generated against Japanese encephalitis virus envelope protein expressed by DNA vaccines under macrophage associated versus ubiquitous expression promoters. Virol J 8:382-392.